Loading...
Development of Levofloxacin inhalation solution to treat Pseudomonas aeruginosa in patients with cystic fibrosis
Inhaled therapies allow for the targeted delivery of antimicrobials directly into the lungs and have been widely used in the treatment of cystic fibrosis (CF) acute pulmonary exacerbations. Nebulized levofloxacin solution (MP-376) is a novel therapy that is currently being evaluated in phase I, II,...
Saved in:
| Published in: | Ther Adv Respir Dis |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5564390/ https://ncbi.nlm.nih.gov/pubmed/24334337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465813508445 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|